First experimental coronavirus vaccine is tested on volunteer

On Monday, U.S. researchers gave a shot of an experimental vaccine for coronavirus to a volunteer. This is the first vaccine to be tested so far.

ADVERTISEMENT
Image
Sam Edwards High Level Alberta
ADVERTISEMENT

On Monday, U.S. researchers gave a shot of an experimental vaccine for coronavirus to a volunteer. This is the first vaccine to be tested so far as the world searches for a solution to the pandemic.

Scientists injected a healthy volunteer with the vaccine at Seattle's Kaiser Permanente Washington Research Institute according to Global News. They are still awaiting results of the first-stage study of the vaccine that was quickly developed.

The leader of the study, Dr. Lisa Jackson said, “We’re team coronavirus now. Everyone wants to do what they can in this emergency.”

The first participant of the study is an operations manager who works for a tech company. Three more people waited in line for the vaccine which will be received by 45 volunteers who will get two doses a month apart from each other.

Jennifer Haller, who is a 43-year-old from Seattle said, “We all feel so helpless. This is an amazing opportunity for me to do something.”

She has two teenagers who “think it’s cool” that she is taking part in the study.

After receiving the injection she said, “I’m feeling great.”

This is the beginning of many studies that have to be done in order to find out whether or not shots will work for the virus. According to Dr. Anthony Fauci from the U.S. National Institutes of Health, if the research goes according to plan we will still have to wait 12 to 18 months for the vaccine to be available for large scale use.

In a statement released on Monday, Fauci noted that getting a vaccine “is an urgent public health priority.”

He added that the recent study, “launched in record speed, is an important first step toward achieving that goal.”

The vaccine was developed at the NIH and Moderna Inc.—a biotech company out of Massachusetts. As the shots do not contain the coronavirus itself, participants have no chance of getting infected.

Another vaccine candidate that will be studied soon has been developed by biotech company—Inovio Pharmaceuticals.

There have now been approximately 180,000 cases of the virus throughout the world while about 78,000 people have made successful recoveries.

ADVERTISEMENT
ADVERTISEMENT

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2024 The Post Millennial, Privacy Policy | Do Not Sell My Personal Information